Decipher Biosciences

Convergent Genomics

This company develops non-invasive urine-based genomic tests to detect and monitor bladder cancer for clinicians and their patients.

Veracyte

This company develops genomic tests and diagnostic tools to help clinicians and patients make informed treatment decisions for various types of cancer.

Artera

This company develops artificial intelligence tests that predict cancer outcomes and treatment benefits for clinicians and their patients.

Delphi Diagnostics

This company develops genomic tests for breast cancer to assist clinicians and patients in personalising treatment decisions and predicting long-term survival outcomes.

PCaVision

This company develops artificial intelligence software that analyses ultrasound recordings to assist urologists with prostate cancer diagnosis and biopsy planning for clinical patients.

Orbit Genomics

This company develops AI-powered genomic tests for healthcare providers and patients to diagnose lung cancer and evaluate risks for chronic diseases.

Foundation Medicine

This company develops genomic profiling tests to help doctors and researchers identify treatment options for cancer patients.

Imagenomix

The company develops an artificial intelligence platform that predicts cancer mutations from pathology images for healthcare providers and biopharma companies.